GEN Exclusives

More »

GEN News Highlights

More »
Dec 13, 2012

eBioscience Sheds Western Blot Line

  • Rockland Immunochemicals today said it expanded its footprint in Western blotting products by acquiring the TrueBlot® IP/Western blot product line from eBioscience for an undisclosed sum, less than a year after all of eBioscience was bought by Affymetrix for $315 million.

    The deal takes eBioscience out of the global Western blotting market, estimated at $1 billion, as the Affymetrix-owned company refocuses toward its evolving flow cytometry, immunoassay, and immunohistochemistry applications in immunology, oncology, and other therapeutic areas.

    Those areas attracted Affymetrix to eBioscience when it acquired the company in an all-cash deal completed in June and explained as improving Affy’s diagnostics business.

    Rockland said it will market the TrueBlot IP/Western blot product line on its e-commerce website and through its existing global distribution network. TrueBlot reagents are designed for researchers to generate publication-quality data from immunoprecipitation and Western blot experiments.

    "The acquisition of the TrueBlot product line expands Rockland’s Western blot workflow product offerings and will allow our customers to perform protein research in a more efficient and effective manner," Jim Fendrick, Rockland’s president and CEO, said in a statement.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?